Ann: First Commercial Sale of APAS Independence, page-42

so what your saying is that our ringmaster has lost credibility and the fund houses think he is a t***** ? and wont shove money into LBT because they sucking lemons ? LOL


Think our lacklustre share price its more about clearing hurdles first before market will take us seriously

Clearing regulatory hurdles

The deal between LBT and St Vincent’s means APAS will be deployed in a clinical “real world” environment and will thereby be subject to a stringent regulatory process.
For APAS to be effective, it must meet all regulatory guidelines including demonstrating the clinical performance of each new analysis module through analytical and performance testing.
According to LBT, following an evaluation of a number of potential service providers, St Vincent’s Hospital was selected to provide these analytical and performance testing services to CCS.
Furthermore, as a result of the six-week trial period, St Vincent’s Hospital has been selected given its familiarity with the instrument and its ability to act as a “centre of excellence” for other potential customers and physicians to observe the instrument in a commercial setting.